Status:
COMPLETED
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Lead Sponsor:
University Hospital, Lille
Conditions:
Dermatomyositis
Polymyositis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy of an active rehabilitation program on disability and quality of life of patients affected by dermatomyositis and polymyositis.
Detailed Description
Dermatomyositis (DM) and polymyositis (PM) are inflammatory disabling neuromuscular disorders. Despite partial benefit of pharmacological treatments, muscle strength, functional status and quality of ...
Eligibility Criteria
Inclusion
- diagnosis of Dermatomyositis ore polymyositis according to the International Myositis Assessment and Clinical Studies Group
- functional impairment (an HAQ score greater than 0.5)
- stability of muscle impairment
- medical insurance
Exclusion
- no recent inflammatory activity
- other chronic disease
- cognitive impairment
- patients who participated to a rehabilitation program before inclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01415219
Start Date
March 1 2008
End Date
December 1 2013
Last Update
December 22 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Lille
Lille, Hauts-de-France, France, 59037
2
Hopital Rotschild
Paris, France, 75571
3
GH Pitié Salpétrière
Paris, France, 75651
4
Hopital Cochin
Paris, France, 75679